Patent · US Active

Humanized anti-CDCP1 antibodies

US9346886B2 · kind B2 · utility

4Cited by

2References

2Claims

0Family size

Assignee

Roche Glycart AG · CH

Inventors

Johannes Auer · Schwaigen, DE
Birgit Bossenmaier · Hanerau-Hademarschen, DE
Guy Georges · Habach, DE
Alexander Lifke · Penzberg, DE
Ekkehard Moessner · Kreuzlingen, CH
Gerhard Niederfellner · Oberhausen, DE

Key dates

Filing date	Dec 20, 2012
Grant date	May 24, 2016
Priority date	—
Expiry date	Jun 26, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to humanized antibodies against human CDCP1 (anti-CDCP1 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.